Marienhospital Bottrop

Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041) (2023) Fasching P, Hein A, Kolberg HC, Häberle L, Uhrig S, Rübner M, Belleville E, et al. Journal article Update Breast Cancer 2022 Part 6 – Advanced-Stage Breast Cancer (2023) Lüftner D, Lux MP, Fehm TN, Welslau M, Müller V, Schütz F, Fasching P, et al. Journal article, Review article Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer (2023) Fehm TN, Welslau M, Müller V, Lüftner D, Schütz F, Fasching P, Janni W, et al. Journal article, Review article Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in Healthcare (2023) Müller V, Fasching P, Nabieva N, Fehm TN, Thill M, Schmidt M, Kühn T, et al. Journal article, Review article Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics – A retrospective analysis of a real world registry (2022) Muller V, Hein A, Hartkopf AD, Fasching P, Kolberg HC, Hadji P, Tesch H, et al. Journal article, Original article Update Breast Cancer 2022 Part 2 - Advanced Stage Breast Cancer (2022) Müller V, Welslau M, Lüftner D, Schütz F, Stickeler E, Fasching P, Janni W, et al. Journal article, Review article Update Breast Cancer 2022 Part 4 - Advanced-Stage Breast Cancer. (2022) Aktas B, Fehm TN, Welslau M, Mueller V, Lueftner D, Schuetz F, Fasching P, et al. Journal article, Review article Update Breast Cancer 2021 Part 4 - Prevention and Early Stages. (2022) Thomssen C, Fehm TN, Stickeler E, Fasching P, Janni W, Kolberg-Liedtke C, Kolberg HC, et al. Journal article, Review article Update Breast Cancer 2021 Part 5 - Advanced Breast Cancer. (2022) Lueftner D, Schuetz F, Stickeler E, Fasching P, Janni W, Kolberg-Liedtke C, Kolberg HC, et al. Journal article, Review article Update Breast Cancer 2022 Part 1 - Early Stage Breast Cancer. (2022) Welslau M, Mueller V, Lueftner D, Schuetz F, Stickeler E, Fasching P, Janni W, et al. Journal article, Review article